ArticleClinical pharmacokinetics2018

Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.

Lena Klopp-Schulze et al.PubMed ↗Publisher ↗

No numbers read from the abstract.